- Home
- / Adare Pharmaceuticals
Adare Pharmaceuticals
Revenue
$687.9 M
FY, 2013
Adare Pharmaceuticals Summary
Company Summary
- Overview
- Adare Pharmaceuticals (formerly Aptalis Pharmaceutical) is a specialty pharmaceutical company developing differentiated products through the application of pharmaceutical technologies. The company focuses on oral dosage forms. Its brands include Lactéol, a pharmabiotic approved to treat diarrhea, and Viactiv, a calcium supplement.
- Type
- Private
- Status
- Active
- Founded
- 2015
- HQ
- Lawrence Township, NJ, US | view all locations
- Website
- https://www.adarepharma.com/
- Cybersecurity rating
Table of Contents
Key People
Michael Ryan, Chief Financial Officer, Chief Operations Officer
Kristin Berkinsky, Chief Human Resources Officer
Russell Lindenfeldar, Chief Legal Officer
Operating MetricsView all
Approval Phase Products
2
Apr, 2020
Pre-Clinical Phase Products
4
Apr, 2020
Phase III Trials Products
1
Apr, 2020
LocationsView all
6 locations detected
Lawrence Township, NJ HQ
United States
1200 Lenox Dr #100
Vandalia, OH
United States
845 Center Dr
Mont-Saint-Hilaire, QC
Canada
Houdan, IDF
France
Route de Bu
Area Industriale, Lombardia
Italy
Via Molise, 16
Pessano Con Bornago, Lombardia
Italy
Via Martin Luther King, 13
Adare Pharmaceuticals Financials
Summary Financials
- Revenue (FY, 2013)
- $687.9M
- Gross profit (FY, 2013)
- $541.3M
- Net income (FY, 2013)
- $86.9M
- Cash (FY, 2013)
- $229.9M
- EBIT (FY, 2013)
- $190.1M